Haoxi Health Technology Enters $6.5M Securities Agreement with Investors
Haoxi Health Technology announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5M of the company's securities, including 9M Class A ordinary shares, par value $0.0025 per share and 16,999,998 pre-funded warrants, at a purchase price of 25c per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 shares. The aggregate gross proceeds to the company of this offering are expected to be approximately $6.5M, before deducting placement agent commissions and other offering expenses. The transaction is expected to close on or about May 12, subject to the satisfaction of customary closing conditions. The company intends to use the net proceeds from this offering for working capital and general corporate purposes. Univest Securities is acting as the sole placement agent.
Trade with 70% Backtested Accuracy
Analyst Views on HAO
About HAO
About the author
Haoxi Health and Eaglepoint AI Sign Strategic Cooperation Agreement
- Strategic Cooperation Agreement: Haoxi Health and Eaglepoint AI have signed a three-year strategic cooperation agreement, committing joint R&D, data, and channel resources to launch an AI health management platform, marking Haoxi's exploration of new opportunities in the AI healthcare sector.
- Innovative Technology Application: This collaboration represents the first deployment of Eaglepoint AI's Aquila data engine and multimodal model evaluation system in a health management scenario, expected to enhance the intelligence of health management and drive the development of preventive healthcare applications.
- Market Promotion Support: Haoxi Health plans to leverage its extensive marketing networks to provide user reach and commercial conversion support, while Eaglepoint AI will handle technical support, including model training and data security compliance, ensuring smooth project execution.
- Phase One Objectives: The initial phase will launch the
Concerns Arise Among Investors Regarding Haoxi Health Technology's (NASDAQ:HAO) Capital Returns
Haoxi Health Technology's Financial Performance: The company has a low return on capital employed (ROCE) of 4.1%, significantly below the media industry average of 9.5%, indicating underperformance despite an increase in capital employed and revenue.
Growth Strategy and Risks: Although Haoxi is reinvesting for growth, leading to higher sales, its stock has plummeted 82% over the past year, suggesting potential underlying issues, including five warning signs that investors should be aware of.
Oxford Industries Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Oxford Industries Earnings Report: Oxford Industries, Inc. shares rose 15.1% in pre-market trading after reporting Q2 earnings of $1.26 per share, exceeding analyst expectations of $1.18, and raising its FY25 EPS guidance despite a revenue miss.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with YY Group Holding Limited gaining 122.9% and Vince Holding Corp rising 101%, while Robin Energy Ltd. and TOP Financial Group Limited experienced declines of 23.5% and 21.6%, respectively.
MongoDB Shares Surge 31%; Check Out 20 Stocks Making Moves in Premarket Trading
MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.
Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).
Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.
Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
Company Announcement: Haoxi Health Technology Limited has launched a customized livestreaming agency strategy through its subsidiary, Haoxi Beijing, aimed at enhancing marketing solutions for the medical aesthetics sector in response to growing consumer demand.
Service Offerings: The new livestreaming services will provide a comprehensive approach including account setup, content planning, and post-campaign analysis, focusing on long-term brand building and improving online conversion rates for clients in the healthcare industry.
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Upstart Holdings Performance: Upstart Holdings, Inc. shares surged 25.5% in pre-market trading after reporting better-than-expected fourth-quarter earnings of 26 cents per share and revenue of $218.96 million, along with optimistic FY25 revenue guidance.
Market Movements: Several stocks experienced significant pre-market gains, including Mynaric AG (+75%) and Windtree Therapeutics, Inc. (+57.3%), while others like Spire Global, Inc. saw a dramatic drop of 49.6% following a legal complaint.
Haoxi Health and Eaglepoint AI Sign Strategic Cooperation Agreement
- Strategic Cooperation Agreement: Haoxi Health and Eaglepoint AI have signed a three-year strategic cooperation agreement, committing joint R&D, data, and channel resources to launch an AI health management platform, marking Haoxi's exploration of new opportunities in the AI healthcare sector.
- Innovative Technology Application: This collaboration represents the first deployment of Eaglepoint AI's Aquila data engine and multimodal model evaluation system in a health management scenario, expected to enhance the intelligence of health management and drive the development of preventive healthcare applications.
- Market Promotion Support: Haoxi Health plans to leverage its extensive marketing networks to provide user reach and commercial conversion support, while Eaglepoint AI will handle technical support, including model training and data security compliance, ensuring smooth project execution.
- Phase One Objectives: The initial phase will launch the
Concerns Arise Among Investors Regarding Haoxi Health Technology's (NASDAQ:HAO) Capital Returns
Haoxi Health Technology's Financial Performance: The company has a low return on capital employed (ROCE) of 4.1%, significantly below the media industry average of 9.5%, indicating underperformance despite an increase in capital employed and revenue.
Growth Strategy and Risks: Although Haoxi is reinvesting for growth, leading to higher sales, its stock has plummeted 82% over the past year, suggesting potential underlying issues, including five warning signs that investors should be aware of.
Oxford Industries Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Oxford Industries Earnings Report: Oxford Industries, Inc. shares rose 15.1% in pre-market trading after reporting Q2 earnings of $1.26 per share, exceeding analyst expectations of $1.18, and raising its FY25 EPS guidance despite a revenue miss.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with YY Group Holding Limited gaining 122.9% and Vince Holding Corp rising 101%, while Robin Energy Ltd. and TOP Financial Group Limited experienced declines of 23.5% and 21.6%, respectively.
MongoDB Shares Surge 31%; Check Out 20 Stocks Making Moves in Premarket Trading
MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.
Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).
Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.
Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
Company Announcement: Haoxi Health Technology Limited has launched a customized livestreaming agency strategy through its subsidiary, Haoxi Beijing, aimed at enhancing marketing solutions for the medical aesthetics sector in response to growing consumer demand.
Service Offerings: The new livestreaming services will provide a comprehensive approach including account setup, content planning, and post-campaign analysis, focusing on long-term brand building and improving online conversion rates for clients in the healthcare industry.
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Upstart Holdings Performance: Upstart Holdings, Inc. shares surged 25.5% in pre-market trading after reporting better-than-expected fourth-quarter earnings of 26 cents per share and revenue of $218.96 million, along with optimistic FY25 revenue guidance.
Market Movements: Several stocks experienced significant pre-market gains, including Mynaric AG (+75%) and Windtree Therapeutics, Inc. (+57.3%), while others like Spire Global, Inc. saw a dramatic drop of 49.6% following a legal complaint.
